Copyright Reports & Markets. All rights reserved.

Global Nuclear Medicine System Market Growth 2019-2024

Buy now

Table of Contents

    2019-2024 Global Nuclear Medicine System Consumption Market Report

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Nuclear Medicine System Consumption 2014-2024
        • 2.1.2 Nuclear Medicine System Consumption CAGR by Region
      • 2.2 Nuclear Medicine System Segment by Type
        • 2.2.1 Single-Photon Emission Computed Tomography (SPECT) Systems
        • 2.2.2 Hybrid Positron Emission Tomography (PET) Systems
        • 2.2.3 Planar Scintigraphy
      • 2.3 Nuclear Medicine System Consumption by Type
        • 2.3.1 Global Nuclear Medicine System Consumption Market Share by Type (2014-2019)
        • 2.3.2 Global Nuclear Medicine System Revenue and Market Share by Type (2014-2019)
        • 2.3.3 Global Nuclear Medicine System Sale Price by Type (2014-2019)
      • 2.4 Nuclear Medicine System Segment by Application
        • 2.4.1 Hospitals
        • 2.4.2 Imaging Centers
        • 2.4.3 Research Institutes
        • 2.4.4 Others
      • 2.5 Nuclear Medicine System Consumption by Application
        • 2.5.1 Global Nuclear Medicine System Consumption Market Share by Application (2014-2019)
        • 2.5.2 Global Nuclear Medicine System Value and Market Share by Application (2014-2019)
        • 2.5.3 Global Nuclear Medicine System Sale Price by Application (2014-2019)

      3 Global Nuclear Medicine System by Players

      • 3.1 Global Nuclear Medicine System Sales Market Share by Players
        • 3.1.1 Global Nuclear Medicine System Sales by Players (2017-2019)
        • 3.1.2 Global Nuclear Medicine System Sales Market Share by Players (2017-2019)
      • 3.2 Global Nuclear Medicine System Revenue Market Share by Players
        • 3.2.1 Global Nuclear Medicine System Revenue by Players (2017-2019)
        • 3.2.2 Global Nuclear Medicine System Revenue Market Share by Players (2017-2019)
      • 3.3 Global Nuclear Medicine System Sale Price by Players
      • 3.4 Global Nuclear Medicine System Manufacturing Base Distribution, Sales Area, Product Types by Players
        • 3.4.1 Global Nuclear Medicine System Manufacturing Base Distribution and Sales Area by Players
        • 3.4.2 Players Nuclear Medicine System Products Offered
      • 3.5 Market Concentration Rate Analysis
        • 3.5.1 Competition Landscape Analysis
        • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.6 New Products and Potential Entrants
      • 3.7 Mergers & Acquisitions, Expansion

      4 Nuclear Medicine System by Regions

      • 4.1 Nuclear Medicine System by Regions
        • 4.1.1 Global Nuclear Medicine System Consumption by Regions
        • 4.1.2 Global Nuclear Medicine System Value by Regions
      • 4.2 Americas Nuclear Medicine System Consumption Growth
      • 4.3 APAC Nuclear Medicine System Consumption Growth
      • 4.4 Europe Nuclear Medicine System Consumption Growth
      • 4.5 Middle East & Africa Nuclear Medicine System Consumption Growth

      5 Americas

      • 5.1 Americas Nuclear Medicine System Consumption by Countries
        • 5.1.1 Americas Nuclear Medicine System Consumption by Countries (2014-2019)
        • 5.1.2 Americas Nuclear Medicine System Value by Countries (2014-2019)
      • 5.2 Americas Nuclear Medicine System Consumption by Type
      • 5.3 Americas Nuclear Medicine System Consumption by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Nuclear Medicine System Consumption by Countries
        • 6.1.1 APAC Nuclear Medicine System Consumption by Countries (2014-2019)
        • 6.1.2 APAC Nuclear Medicine System Value by Countries (2014-2019)
      • 6.2 APAC Nuclear Medicine System Consumption by Type
      • 6.3 APAC Nuclear Medicine System Consumption by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Nuclear Medicine System by Countries
        • 7.1.1 Europe Nuclear Medicine System Consumption by Countries (2014-2019)
        • 7.1.2 Europe Nuclear Medicine System Value by Countries (2014-2019)
      • 7.2 Europe Nuclear Medicine System Consumption by Type
      • 7.3 Europe Nuclear Medicine System Consumption by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Nuclear Medicine System by Countries
        • 8.1.1 Middle East & Africa Nuclear Medicine System Consumption by Countries (2014-2019)
        • 8.1.2 Middle East & Africa Nuclear Medicine System Value by Countries (2014-2019)
      • 8.2 Middle East & Africa Nuclear Medicine System Consumption by Type
      • 8.3 Middle East & Africa Nuclear Medicine System Consumption by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Marketing, Distributors and Customer

      • 10.1 Sales Channel
        • 10.1.1 Direct Channels
        • 10.1.2 Indirect Channels
      • 10.2 Nuclear Medicine System Distributors
      • 10.3 Nuclear Medicine System Customer

      11 Global Nuclear Medicine System Market Forecast

      • 11.1 Global Nuclear Medicine System Consumption Forecast (2019-2024)
      • 11.2 Global Nuclear Medicine System Forecast by Regions
        • 11.2.1 Global Nuclear Medicine System Forecast by Regions (2019-2024)
        • 11.2.2 Global Nuclear Medicine System Value Forecast by Regions (2019-2024)
        • 11.2.3 Americas Consumption Forecast
        • 11.2.4 APAC Consumption Forecast
        • 11.2.5 Europe Consumption Forecast
        • 11.2.6 Middle East & Africa Consumption Forecast
      • 11.3 Americas Forecast by Countries
        • 11.3.1 United States Market Forecast
        • 11.3.2 Canada Market Forecast
        • 11.3.3 Mexico Market Forecast
        • 11.3.4 Brazil Market Forecast
      • 11.4 APAC Forecast by Countries
        • 11.4.1 China Market Forecast
        • 11.4.2 Japan Market Forecast
        • 11.4.3 Korea Market Forecast
        • 11.4.4 Southeast Asia Market Forecast
        • 11.4.5 India Market Forecast
        • 11.4.6 Australia Market Forecast
      • 11.5 Europe Forecast by Countries
        • 11.5.1 Germany Market Forecast
        • 11.5.2 France Market Forecast
        • 11.5.3 UK Market Forecast
        • 11.5.4 Italy Market Forecast
        • 11.5.5 Russia Market Forecast
        • 11.5.6 Spain Market Forecast
      • 11.6 Middle East & Africa Forecast by Countries
        • 11.6.1 Egypt Market Forecast
        • 11.6.2 South Africa Market Forecast
        • 11.6.3 Israel Market Forecast
        • 11.6.4 Turkey Market Forecast
        • 11.6.5 GCC Countries Market Forecast
      • 11.7 Global Nuclear Medicine System Forecast by Type
      • 11.8 Global Nuclear Medicine System Forecast by Application

      12 Key Players Analysis

      • 12.1 Siemens Healthineers
        • 12.1.1 Company Details
        • 12.1.2 Nuclear Medicine System Product Offered
        • 12.1.3 Siemens Healthineers Nuclear Medicine System Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.1.4 Main Business Overview
        • 12.1.5 Siemens Healthineers News
      • 12.2 Koninklijke Philips
        • 12.2.1 Company Details
        • 12.2.2 Nuclear Medicine System Product Offered
        • 12.2.3 Koninklijke Philips Nuclear Medicine System Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.2.4 Main Business Overview
        • 12.2.5 Koninklijke Philips News
      • 12.3 GE Healthcare
        • 12.3.1 Company Details
        • 12.3.2 Nuclear Medicine System Product Offered
        • 12.3.3 GE Healthcare Nuclear Medicine System Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.3.4 Main Business Overview
        • 12.3.5 GE Healthcare News
      • 12.4 Neusoft Medical Systems
        • 12.4.1 Company Details
        • 12.4.2 Nuclear Medicine System Product Offered
        • 12.4.3 Neusoft Medical Systems Nuclear Medicine System Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.4.4 Main Business Overview
        • 12.4.5 Neusoft Medical Systems News
      • 12.5 Mediso Medical Imaging Systems
        • 12.5.1 Company Details
        • 12.5.2 Nuclear Medicine System Product Offered
        • 12.5.3 Mediso Medical Imaging Systems Nuclear Medicine System Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.5.4 Main Business Overview
        • 12.5.5 Mediso Medical Imaging Systems News
      • 12.6 Digirad
        • 12.6.1 Company Details
        • 12.6.2 Nuclear Medicine System Product Offered
        • 12.6.3 Digirad Nuclear Medicine System Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.6.4 Main Business Overview
        • 12.6.5 Digirad News
      • 12.7 SurgicEye
        • 12.7.1 Company Details
        • 12.7.2 Nuclear Medicine System Product Offered
        • 12.7.3 SurgicEye Nuclear Medicine System Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.7.4 Main Business Overview
        • 12.7.5 SurgicEye News
      • 12.8 Positron
        • 12.8.1 Company Details
        • 12.8.2 Nuclear Medicine System Product Offered
        • 12.8.3 Positron Nuclear Medicine System Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.8.4 Main Business Overview
        • 12.8.5 Positron News

      13 Research Findings and Conclusion

      Nuclear medicine is a medical specialty that uses radioactive tracers (radiopharmaceuticals) to assess bodily functions and to diagnose and treat disease. Specially designed cameras allow doctors to track the path of these radioactive tracers. Single Photon Emission Computed Tomography or SPECT and Positron Emission Tomography or PET scans are the two most common imaging modalities in nuclear medicine.

      According to this study, over the next five years the Nuclear Medicine System market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Nuclear Medicine System business, shared in Chapter 3.

      This report presents a comprehensive overview, market shares, and growth opportunities of Nuclear Medicine System market by product type, application, key manufacturers and key regions and countries.

      This study considers the Nuclear Medicine System value and volume generated from the sales of the following segments:

      Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
      Single-Photon Emission Computed Tomography (SPECT) Systems
      Hybrid Positron Emission Tomography (PET) Systems
      Planar Scintigraphy
      Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
      Hospitals
      Imaging Centers
      Research Institutes
      Others

      This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
      Americas
      United States
      Canada
      Mexico
      Brazil
      APAC
      China
      Japan
      Korea
      Southeast Asia
      India
      Australia
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Middle East & Africa
      Egypt
      South Africa
      Israel
      Turkey
      GCC Countries

      The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
      Siemens Healthineers
      Koninklijke Philips
      GE Healthcare
      Neusoft Medical Systems
      Mediso Medical Imaging Systems
      Digirad
      SurgicEye
      Positron

      In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

      Research objectives
      To study and analyze the global Nuclear Medicine System consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
      To understand the structure of Nuclear Medicine System market by identifying its various subsegments.
      Focuses on the key global Nuclear Medicine System manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
      To analyze the Nuclear Medicine System with respect to individual growth trends, future prospects, and their contribution to the total market.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      To project the consumption of Nuclear Medicine System submarkets, with respect to key regions (along with their respective key countries).
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
      To strategically profile the key players and comprehensively analyze their growth strategies.

      Buy now